Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
EsoCap Logo
EsoCap Growth Score
80
CB Rank
442469
Heat Score
70
EsoCap is a Biotechnology Research company.
Founded
obfuscation
PrivateFunding Round Basel, Basel-Stadt, Switzerland1-10 esocapbiotech.ch
Biotechnology
Overview

EsoCap
Growth Score
80
Heat Score
70

Growth Score80
-7 pts
in past quarter
Heat Score 70
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About EsoCap

CB Rank
442469
EsoCap is a Biotechnology Research company.
Founded
obfuscation
PrivateFunding Round Basel, Basel-Stadt, Switzerland1-10 esocapbiotech.ch
Biotechnology

Funding Rounds

Funding Round
OBF
in
obfuscation

Key People

Details

Also Known As EsoCap AG
Operating Status Active
Company Type For Profit
About the Company

EsoCap is the operator of a drug delivery platform designed for the treatment of diseases of the upper gastrointestinal tract. The company's technology offers targeted and long-lasting treatment of patients' esophageal mucosa using a capsule containing a thin film loaded with a drug, enabling patients with esophageal diseases to improve

their lives.

Phone Number +41 61 515 0777
Contact Email office@esocapbiotech.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

EsoCap Technology
A drug delivery platform that enables targeted, long-lasting topical application of therapeutic agents to the esophagus, enhancing mucosal contact time and drug deposition for effective treatment of esophageal diseases.
ESO-101
A lead product candidate consisting of a capsule with a mucoadhesive film containing mometasone furoate, designed for the treatment of eosinophilic esophagitis by providing localized delivery to the esophageal lining.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round
obfuscation
Funding Round - EsoCap Logo
Funding Round - EsoCap
—
obfuscation
— Funding Round

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Sep 5, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 14, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

73
58.7%
 in past month

IT Spend

$105.6KThis year, EsoCap is projected to spend $105.6K on IT, according to Aberdeen.

Active Website Tech Count

4EsoCap is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  CloudFront.

Total IP

12The intellectual property of EsoCap includes 12 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is EsoCap's headquarters? EsoCap is located in Basel, Basel-Stadt, Switzerland.When was the last funding round for EsoCap? EsoCap closed its last funding round on
obfuscation
from a Undisclosed round.Who are EsoCap's competitors? Alternatives and possible competitors to EsoCap may include Takeda, Medtronic, and  Bausch Health.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|